bpc-157 human evidence clinical trials FDA Approval Status: Is It Approved for Use? bpc-157 human clinical trials evidence
Description
Independent verification for identity, purity, and potency, with viewable Certificates of Authenticity, provides objective quality confirmation rather than relying solely on manufacturer statements
Telomerase helps counteract telomere shortening by adding back nucleotide sequences to the chromosome ends
No cases of Bell's palsy were reported in the placebo group
Research shows improvements in metabolic markers including insulin sensitivity and inflammatory markers, likely secondary to visceral fat reduction
